Objective: The aim of this study is to identify and describe the processes suggested for the formulation of healthcare recommendations in healthcare guidelines available in guidance documents.
Methods: We searched international databases in May 2020 to retrieve guidance documents published by organizations dedicated to guideline development. Pairs of researchers independently selected and extracted data about the characteristics of the guidance document, including explicit or implicit recommendation-related criteria and processes considered, as well as the use of evidence to decision (EtD) frameworks.
Results: We included 68 guidance documents. Most organizations reported a system for grading the strength of recommendations (88%), half of them being the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach. Two out of three guidance documents (66%) proposed the use of a framework to guide the EtD process. The GRADE-EtD framework was the most often reported framework (19 organizations, 42%), whereas 20 organizations (44%) proposed their own multicriteria frameworks. Using any EtD framework was related with a more comprehensive set of recommendation-related criteria compared to no framework, especially for criteria like values, equity, and acceptability.
Conclusion: Although limited, the use of EtD frameworks was associated with the inclusion of relevant recommendation criteria. Among the EtD structured frameworks, the GRADE-EtD framework offers the most comprehensive perspective for evidence-informed decision-making processes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jclinepi.2022.06.004 | DOI Listing |
Introduction: There is a move towards engaging people with lived experience and families (PWLE/F)-also referred to as PWLE/F engagement-in mental health and/or substance use research. However, PWLE/F engagement is inadequately reported on in mental health and/or substance use research papers.
Objective: To understand what PWLE/F and researchers perceive are important components to report on related to engagement in mental health and/or substance use research.
J Appl Clin Med Phys
March 2025
Kaiser Permanente Southern California Medical Group, Pasadena, California, USA.
The Mammography Quality Standards Act (MQSA) sets quality standards for displays used to interpret mammography images. With the shift to digital mammography and the widespread use of remote reading workstations (RWS), updated quality management (QM) programs are needed to ensure consistent image presentation and accurate interpretation. This document recommends a QM framework for mammography RWS displays, addressing challenges such as remote environments, regulatory compliance, and evolving technology.
View Article and Find Full Text PDFJ Opioid Manag
March 2025
Outpatient Chronic Pain Clinical Pharmacist Practitioner, VA Salt Lake City Health Care System, Salt Lake City, Utah.
Objective: Create a standardized protocol document on how to convert patients from full opioid agonist to buprenorphine. Providing patients with the best possible chance of a seamless conversion resulting in decreased risk of failure of therapy with buprenorphine.
Methods: A 10-question survey was distributed to better understand the different aspects the providers consider when converting a patient from full opioid agonist to buprenorphine.
J Emerg Manag
March 2025
Georgetown University, Washington, DC. ORCID: https://orcid.org/0009-0008-0908-6783.
Active shooter planning for special education classrooms requires considerations commensurate to the needs of students with mobility, cognitive, auditory, visual, and communicative limitations. The federally established Run, Hide, Fight response methodology has no modified alternative for students who are not able to meet the criteria to run, hide, or fight. School districts that implement Run, Hide, Fight plans without any modified alternatives for special education students expose a compliance lapse of the American Disabilities Act, the Department of Education's Individuals with Disabilities Education Act, and the National Preparedness Goal.
View Article and Find Full Text PDFArch Gynecol Obstet
March 2025
Department for Gynecology, Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Introduction: Homologous recombination deficiency (HRD) is a key biomarker in the management of high-grade serous ovarian cancer (HGSOC), guiding treatment decisions, particularly regarding the use of poly(ADP-ribose) polymerase inhibitors (PARPi). As multiple HRD assays are available, each with distinct methodologies and cutoff values, the interpretation and clinical application of HRD testing remain complex. This intergroup statement, endorsed by the German Ovarian Cancer Commission, NOGGO, AGO Austria, and AGO Swiss, aims to provide guidance on the indications, appropriate use, and limitations of HRD testing in ovarian cancer.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!